Published in Blood on April 01, 1992
Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol (2011) 2.82
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients. Blood (2011) 2.72
Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM). Oncology (Williston Park) (2011) 2.21
Transthyretin (TTR) cardiac amyloidosis. Circulation (2012) 1.40
Al amyloidosis. Orphanet J Rare Dis (2012) 1.29
Systemic amyloidosis in England: an epidemiological study. Br J Haematol (2013) 1.08
Progression in smoldering Waldenstrom macroglobulinemia: long-term results. Blood (2012) 1.06
Comparison of amyloid fibril formation by two closely related immunoglobulin light chain variable domains. Amyloid (2010) 1.03
Incidence and survival in non-hereditary amyloidosis in Sweden. BMC Public Health (2012) 0.96
Natural history and therapy of AL cardiac amyloidosis. Heart Fail Rev (2015) 0.96
Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol (2014) 0.95
Cardiac amyloidosis responding to bortezomib: case report and review of literature. Curr Cardiol Rev (2009) 0.90
A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dimer-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci U S A (1996) 0.89
Germ line origin and somatic mutations determine the target tissues in systemic AL-amyloidosis. PLoS One (2007) 0.89
Clinical course of light-chain smouldering multiple myeloma (idiopathic Bence Jones proteinuria): a retrospective cohort study. Lancet Haematol (2014) 0.86
Incidence of hereditary amyloidosis and autoinflammatory diseases in Sweden: endemic and imported diseases. BMC Med Genet (2013) 0.84
Ultrasound-guided percutaneous renal biopsy-induced accessory renal artery bleeding in an amyloidosis patient. Diagn Pathol (2012) 0.84
The Prevalence and Management of Systemic Amyloidosis in Western Countries. Kidney Dis (Basel) (2016) 0.84
Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium. Adv Ther (2015) 0.82
Paraprotein-Related Kidney Disease: Glomerular Diseases Associated with Paraproteinemias. Clin J Am Soc Nephrol (2016) 0.81
Primary systemic amyloidosis with extensive gastrointestinal involvement. Case Rep Gastroenterol (2013) 0.80
Modified high-dose melphalan and autologous SCT for AL amyloidosis or high-risk myeloma: analysis of SWOG trial S0115. Bone Marrow Transplant (2013) 0.80
Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury? Clin J Am Soc Nephrol (2016) 0.80
Role of high-dose melphalan and autologous peripheral blood stem cell transplantation in AL amyloidosis. Am J Blood Res (2012) 0.78
Recent advances in the noninvasive strategies of cardiac amyloidosis. Heart Fail Rev (2016) 0.77
Gastrointestinal Amyloidosis: Review of the Literature. Cureus (2017) 0.75
Bilateral Chronic Subdural Nontraumatic Hematoma in a Woman Affected by AL Amyloidosis. J Neurol Surg Rep (2015) 0.75
Apolipoprotein C-II Deposition Amyloidosis: A Potential Misdiagnosis as Light Chain Amyloidosis. Case Rep Nephrol (2016) 0.75
Progressively invalidating orthostatic hypotension: A common symptom for a challenging diagnosis. J Res Med Sci (2016) 0.75
Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis. Circulation (2017) 0.75
Aggregation of Full Length Immunoglobulin Light Chains from AL Amyloidosis Patients Is Remodeled by Epigallocatechin-3-gallate. J Biol Chem (2016) 0.75
Bladder perforation secondary to primary systemic amyloidosis. Case Rep Urol (2014) 0.75
Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract. BMJ Case Rep (2011) 0.75
Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis. Leukemia (2016) 0.75
Cancer-testis antigen expression and immunogenicity in AL amyloidosis. Blood Cancer J (2012) 0.75
The burden of amyloid light chain amyloidosis on health-related quality of life. Orphanet J Rare Dis (2017) 0.75
Incidence of Tuberculosis and Amyloidosis among Sudanese Patients Presented with Enlarged Nodes. J Trop Med (2014) 0.75
Robert Arthur Kyle, MD: a conversation with the editor. Proc (Bayl Univ Med Cent) (2010) 0.75
Bence Jones protein in primary systemic amyloidosis. Blood (1993) 0.75
Rare presentation of primary (AL) amyloidosis as gastrointestinal hemorrhage without systemic involvement. World J Gastrointest Endosc (2014) 0.75
Acute limb ischemia in a patient with cardiac amyloidosis: a case report. Cases J (2009) 0.75
Amyloidosis involving the respiratory system: 5-year's experience of a multi-disciplinary group's activity. Ann Thorac Med (2015) 0.75
Secondary intestinal amyloidosis presenting intractable hematochezia: a case report and literature review. Int J Clin Exp Pathol (2014) 0.75
Insight into the Protein Composition of Immunoglobulin Light Chain Deposits of Eyelid, Orbital and Conjunctival Amyloidosis. J Proteomics Bioinform (2014) 0.75
2A4 binds soluble and insoluble light chain aggregates from AL amyloidosis patients and promotes clearance of amyloid deposits by phagocytosis (†). Amyloid (2016) 0.75
A case of primary (AL) amyloidosis with predominantly vascular amyloid deposition in the kidney. CEN Case Rep (2014) 0.75
Utility of abdominal skin plus subcutaneous fat and rectal mucosal biopsy in the diagnosis of AL amyloidosis with renal involvement. PLoS One (2017) 0.75
Bilateral multifocal lower extremity localized soft tissue amyloidomas: case report with ultrasonographic characterization. Skeletal Radiol (2017) 0.75
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response. Heart (2017) 0.75
[Causes and treatment of systemic amyloidosis]. Z Rheumatol (2016) 0.75
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
The patient record in epidemiology. Sci Am (1981) 10.32
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia (1993) 6.32
Primary systemic amyloidosis: clinical and laboratory features in 474 cases. Semin Hematol (1995) 5.51
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
The fine structure of some intraganglionic alterations. Neurofibrillary tangles, granulovacuolar bodies and "rod-like" structures as seen in Guam amyotrophic lateral sclerosis and parkinsonism-dementia complex. J Neuropathol Exp Neurol (1968) 4.14
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Trauma and multiple sclerosis: a population-based cohort study from Olmsted County, Minnesota. Neurology (1993) 4.04
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma. Leukemia (2007) 3.95
Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA (1995) 3.84
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia (1975) 3.67
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62
Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40
Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med (1982) 3.30
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
The incidence, causes, and secular trends of head trauma in Olmsted County, Minnesota, 1935-1974. Neurology (1980) 3.23
Factors prognostic of unprovoked seizures after febrile convulsions. N Engl J Med (1987) 3.21
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Familial amyotrophic lateral sclerosis. A subgroup characterized by posterior and spinocerebellar tract involvement and hyaline inclusions in the anterior horn cells. Arch Neurol (1967) 3.04
Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia (1991) 3.02
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98
Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med (1999) 2.98
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Diabetes mellitus: incidence, prevalence, survivorship, and causes of death in Rochester, Minnesota, 1945-1970. Diabetes (1976) 2.89
Seizures after head trauma: a population study. Neurology (1980) 2.87
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83
Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80
Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Mayo Clinic Alzheimer's Disease Patient Registry. Aging (Milano) (1990) 2.77
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
Genetic aberrations and survival in plasma cell leukemia. Leukemia (2008) 2.69
Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils. J Histochem Cytochem (1974) 2.69
Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68
A trial of three regimens for primary amyloidosis: colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med (1997) 2.66
Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Amyotrophic lateral sclerosis and Parkinsonism-dementia complex on Guam. Further pathologic studies. Arch Neurol (1966) 2.58
Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56
The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum (1999) 2.50
Long-term survival of a cohort of community residents with asthma. N Engl J Med (1994) 2.47
Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis (2007) 2.46
Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab (2001) 2.43
Emotional responses of athletes to injury. Mayo Clin Proc (1990) 2.43
Accuracy of the death certificate in a population-based study of asthmatic patients. JAMA (1993) 2.42
Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischemia. Mayo Clin Proc (1981) 2.41
Secular trends in the incidence of hip fractures. Calcif Tissue Int (1987) 2.40
Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption, and bone loss at tissue and cellular levels. J Bone Miner Res (1990) 2.39
50-year trends in the incidence of anorexia nervosa in Rochester, Minn.: a population-based study. Am J Psychiatry (1991) 2.38
Osteoporosis and the risk of hip fracture. Am J Epidemiol (1986) 2.35
Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis (2003) 2.34
Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol (1999) 2.34
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma. Leukemia (2003) 2.28
Incidence and clinical features of trigeminal neuralgia, Rochester, Minnesota, 1945-1984. Ann Neurol (1990) 2.27
The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med (1995) 2.27
Impact of referral bias on clinical and epidemiological studies of Alzheimer's disease. J Clin Epidemiol (1996) 2.27
Vertebral fractures predict subsequent fractures. Osteoporos Int (1999) 2.24
Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980. Am J Kidney Dis (1983) 2.22
Guillain-Barré syndrome: a 42-year epidemiologic and clinical study. Mayo Clin Proc (1978) 2.22
Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int (2008) 2.21
Alzheimer's disease and cumulative exposure to anesthesia: a case-control study. J Am Geriatr Soc (1994) 2.21
Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol (1984) 2.19
Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc (2001) 2.17
Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984) Neurology (1996) 2.16
How frequently does classic amyotrophic lateral sclerosis develop in survivors of poliomyelitis? Neurology (1990) 2.16
Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr Opin Hematol (2000) 2.11